Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-05-04

AUTHORS

Nishant Tageja, Neha Korde, Dickran Kazandjian, Sandhya Panch, Elisabet Manasanch, Manisha Bhutani, Mary Kwok, Sham Mailankody, Constance Yuan, Maryalice Stetler-Stevenson, Susan F. Leitman, Claude Sportes, Ola Landgren

ABSTRACT

Still, many physicians give 4 cycles of combination therapy to multiple myeloma patients prior to collection of stem cells for autologous bone marrow transplant. This tradition originates from older doxorubicin-containing regiments which limited the number of cycles due to cumulative cardiotoxicity. Using older regiments, most patients had residual myeloma cells in their autologous stem-cell grafts during collection. Emerging data show that newly diagnosed multiple myeloma patients treated with modern carfilzomib/lenalidomide/dexamethasone (KRd) therapy, on average, take 6 cycles until reaching minimal residual disease (MRD) negativity. We assessed newly diagnosed patients treated with KRd focusing MRD status both in the individual patient's bone marrow, and the corresponding autologous hematopoietic progenitor cell grafts during collection. Per protocol, stem-cell collection was allowed after 4 to 8 cycles of KRd. We found similar stem-cell yield independent of the number of cycles of KRd. At stem-cell collection, 11/30 patients (36.6%) were MRD negative in their bone marrow; all 11 patients had MRD negative hematopoietic progenitor cell grafts. Furthermore, 18/19 patients who were MRD positive in their bone marrows also had MRD negative hematopoietic progenitor cell grafts. These observations support 6 cycles of KRd as an efficacious and safe induction strategy prior to stem-cell collection. More... »

PAGES

1-5

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41409-018-0170-0

DOI

http://dx.doi.org/10.1038/s41409-018-0170-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103754036

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29728700


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Wheeling Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417082.8", 
          "name": [
            "Division of Hematology/Oncology, Schiffler Cancer Center, Wheeling, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tageja", 
        "givenName": "Nishant", 
        "id": "sg:person.01320171063.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320171063.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Memorial Sloan Kettering Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Korde", 
        "givenName": "Neha", 
        "id": "sg:person.01027216756.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027216756.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes of Health", 
          "id": "https://www.grid.ac/institutes/grid.94365.3d", 
          "name": [
            "Myeloma Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kazandjian", 
        "givenName": "Dickran", 
        "id": "sg:person.01331512034.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331512034.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes of Health Clinical Center", 
          "id": "https://www.grid.ac/institutes/grid.410305.3", 
          "name": [
            "Cell Processing Section, Clinical Center, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Panch", 
        "givenName": "Sandhya", 
        "id": "sg:person.01073457472.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073457472.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Lymphoma and Myeloma, MD Anderson Cancer Center, University of Texas, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manasanch", 
        "givenName": "Elisabet", 
        "id": "sg:person.0640361324.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640361324.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Levine Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.468189.a", 
          "name": [
            "Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bhutani", 
        "givenName": "Manisha", 
        "id": "sg:person.01255463326.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255463326.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Walter Reed National Military Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.414467.4", 
          "name": [
            "Hematology/Oncology Department, John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwok", 
        "givenName": "Mary", 
        "id": "sg:person.01025765740.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025765740.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Memorial Sloan Kettering Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mailankody", 
        "givenName": "Sham", 
        "id": "sg:person.01022655101.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022655101.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes of Health", 
          "id": "https://www.grid.ac/institutes/grid.94365.3d", 
          "name": [
            "Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yuan", 
        "givenName": "Constance", 
        "id": "sg:person.0640367641.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640367641.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes of Health", 
          "id": "https://www.grid.ac/institutes/grid.94365.3d", 
          "name": [
            "Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stetler-Stevenson", 
        "givenName": "Maryalice", 
        "id": "sg:person.01263341253.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263341253.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes of Health Clinical Center", 
          "id": "https://www.grid.ac/institutes/grid.410305.3", 
          "name": [
            "Cell Processing Section, Clinical Center, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leitman", 
        "givenName": "Susan F.", 
        "id": "sg:person.01312177474.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312177474.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Augusta University", 
          "id": "https://www.grid.ac/institutes/grid.410427.4", 
          "name": [
            "Bone Marrow and Stem Cell Transplantation Program, Augusta University, Augusta, GA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sportes", 
        "givenName": "Claude", 
        "id": "sg:person.01347475463.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347475463.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Memorial Sloan Kettering Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Landgren", 
        "givenName": "Ola", 
        "id": "sg:person.0651746766.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651746766.54"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.leu.2404801", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011029060", 
          "https://doi.org/10.1038/sj.leu.2404801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2016-03-705319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015788731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaoncol.2015.2010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030075938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-03-143677", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038113449"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.leukres.2013.12.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038752219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2016.24", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039064722", 
          "https://doi.org/10.1038/bmt.2016.24"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.10535", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039410376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30206-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042996950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.17.3771", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074873336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083110094", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083111450", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-05-04", 
    "datePublishedReg": "2018-05-04", 
    "description": "Still, many physicians give 4 cycles of combination therapy to multiple myeloma patients prior to collection of stem cells for autologous bone marrow transplant. This tradition originates from older doxorubicin-containing regiments which limited the number of cycles due to cumulative cardiotoxicity. Using older regiments, most patients had residual myeloma cells in their autologous stem-cell grafts during collection. Emerging data show that newly diagnosed multiple myeloma patients treated with modern carfilzomib/lenalidomide/dexamethasone (KRd) therapy, on average, take 6 cycles until reaching minimal residual disease (MRD) negativity. We assessed newly diagnosed patients treated with KRd focusing MRD status both in the individual patient's bone marrow, and the corresponding autologous hematopoietic progenitor cell grafts during collection. Per protocol, stem-cell collection was allowed after 4 to 8 cycles of KRd. We found similar stem-cell yield independent of the number of cycles of KRd. At stem-cell collection, 11/30 patients (36.6%) were MRD negative in their bone marrow; all 11 patients had MRD negative hematopoietic progenitor cell grafts. Furthermore, 18/19 patients who were MRD positive in their bone marrows also had MRD negative hematopoietic progenitor cell grafts. These observations support 6 cycles of KRd as an efficacious and safe induction strategy prior to stem-cell collection.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/s41409-018-0170-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "type": "Periodical"
      }
    ], 
    "name": "Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma", 
    "pagination": "1-5", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "9e4a237eaa44118dde33f298ecb6f80adb04cea02c790b150819fd87e57020f8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29728700"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8702459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41409-018-0170-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103754036"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41409-018-0170-0", 
      "https://app.dimensions.ai/details/publication/pub.1103754036"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000493.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/s41409-018-0170-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41409-018-0170-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41409-018-0170-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41409-018-0170-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41409-018-0170-0'


 

This table displays all metadata directly associated to this object as RDF triples.

201 TRIPLES      21 PREDICATES      37 URIs      18 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41409-018-0170-0 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nf24764abbc2d4a2d9bd14897f4f8cca9
4 schema:citation sg:pub.10.1038/bmt.2016.24
5 sg:pub.10.1038/sj.leu.2404801
6 https://app.dimensions.ai/details/publication/pub.1083110094
7 https://app.dimensions.ai/details/publication/pub.1083111450
8 https://doi.org/10.1001/jamaoncol.2015.2010
9 https://doi.org/10.1016/j.leukres.2013.12.007
10 https://doi.org/10.1016/s1470-2045(16)30206-6
11 https://doi.org/10.1182/blood-2008-03-143677
12 https://doi.org/10.1182/blood-2016-03-705319
13 https://doi.org/10.1200/jco.2001.19.17.3771
14 https://doi.org/10.3324/haematol.10535
15 schema:datePublished 2018-05-04
16 schema:datePublishedReg 2018-05-04
17 schema:description Still, many physicians give 4 cycles of combination therapy to multiple myeloma patients prior to collection of stem cells for autologous bone marrow transplant. This tradition originates from older doxorubicin-containing regiments which limited the number of cycles due to cumulative cardiotoxicity. Using older regiments, most patients had residual myeloma cells in their autologous stem-cell grafts during collection. Emerging data show that newly diagnosed multiple myeloma patients treated with modern carfilzomib/lenalidomide/dexamethasone (KRd) therapy, on average, take 6 cycles until reaching minimal residual disease (MRD) negativity. We assessed newly diagnosed patients treated with KRd focusing MRD status both in the individual patient's bone marrow, and the corresponding autologous hematopoietic progenitor cell grafts during collection. Per protocol, stem-cell collection was allowed after 4 to 8 cycles of KRd. We found similar stem-cell yield independent of the number of cycles of KRd. At stem-cell collection, 11/30 patients (36.6%) were MRD negative in their bone marrow; all 11 patients had MRD negative hematopoietic progenitor cell grafts. Furthermore, 18/19 patients who were MRD positive in their bone marrows also had MRD negative hematopoietic progenitor cell grafts. These observations support 6 cycles of KRd as an efficacious and safe induction strategy prior to stem-cell collection.
18 schema:genre research_article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf sg:journal.1096890
22 schema:name Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma
23 schema:pagination 1-5
24 schema:productId N5055fbfdb39f4ccc997471169db098a6
25 N63212ce75c2440ad875f2ec573f0b6b4
26 N9603bf9fdc0c4461bd3790d191e241ee
27 Ne1ec2a686dc94d71b143361d5bd4400e
28 Nfac8090dd0b44c4abfc5c63696c4071e
29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103754036
30 https://doi.org/10.1038/s41409-018-0170-0
31 schema:sdDatePublished 2019-04-10T17:27
32 schema:sdLicense https://scigraph.springernature.com/explorer/license/
33 schema:sdPublisher N5daf6f92d73a42f599a0bf2b6c829292
34 schema:url https://www.nature.com/articles/s41409-018-0170-0
35 sgo:license sg:explorer/license/
36 sgo:sdDataset articles
37 rdf:type schema:ScholarlyArticle
38 N12d34ef5d9154176a512cf7384c62770 rdf:first sg:person.01073457472.48
39 rdf:rest Nd4971ce152104671ab8999da91992c8b
40 N1a32ff7aa2f04d42b47de87b004a0070 rdf:first sg:person.0640367641.74
41 rdf:rest N39288b96dbd7464980111380bbf02024
42 N20448333467e4335bcee6e358258f0db schema:name Department of Lymphoma and Myeloma, MD Anderson Cancer Center, University of Texas, Houston, TX, USA
43 rdf:type schema:Organization
44 N27d3bfccee624e3297a5ba11a0294024 rdf:first sg:person.01027216756.04
45 rdf:rest N8a5b2471fe3842e6b101e16204d7746c
46 N2a2e86d995f4473698939b8b2ebdc54e rdf:first sg:person.01255463326.16
47 rdf:rest N51f404d8359a4fd49b7925e38c8d82a0
48 N39288b96dbd7464980111380bbf02024 rdf:first sg:person.01263341253.41
49 rdf:rest N62d629b412b54604bc33db4414d6874a
50 N468cf40115934ed88aa1b7ad4ea5c387 rdf:first sg:person.01347475463.08
51 rdf:rest Nab507f9552b84ce2a610b983c5f16166
52 N5055fbfdb39f4ccc997471169db098a6 schema:name readcube_id
53 schema:value 9e4a237eaa44118dde33f298ecb6f80adb04cea02c790b150819fd87e57020f8
54 rdf:type schema:PropertyValue
55 N51f404d8359a4fd49b7925e38c8d82a0 rdf:first sg:person.01025765740.48
56 rdf:rest Nc0d33089c3c74a3ebeac747727de9bdb
57 N5daf6f92d73a42f599a0bf2b6c829292 schema:name Springer Nature - SN SciGraph project
58 rdf:type schema:Organization
59 N62d629b412b54604bc33db4414d6874a rdf:first sg:person.01312177474.73
60 rdf:rest N468cf40115934ed88aa1b7ad4ea5c387
61 N63212ce75c2440ad875f2ec573f0b6b4 schema:name doi
62 schema:value 10.1038/s41409-018-0170-0
63 rdf:type schema:PropertyValue
64 N8a5b2471fe3842e6b101e16204d7746c rdf:first sg:person.01331512034.78
65 rdf:rest N12d34ef5d9154176a512cf7384c62770
66 N9603bf9fdc0c4461bd3790d191e241ee schema:name pubmed_id
67 schema:value 29728700
68 rdf:type schema:PropertyValue
69 Nab507f9552b84ce2a610b983c5f16166 rdf:first sg:person.0651746766.54
70 rdf:rest rdf:nil
71 Nc0d33089c3c74a3ebeac747727de9bdb rdf:first sg:person.01022655101.07
72 rdf:rest N1a32ff7aa2f04d42b47de87b004a0070
73 Nd4971ce152104671ab8999da91992c8b rdf:first sg:person.0640361324.84
74 rdf:rest N2a2e86d995f4473698939b8b2ebdc54e
75 Ne1ec2a686dc94d71b143361d5bd4400e schema:name dimensions_id
76 schema:value pub.1103754036
77 rdf:type schema:PropertyValue
78 Nf24764abbc2d4a2d9bd14897f4f8cca9 rdf:first sg:person.01320171063.03
79 rdf:rest N27d3bfccee624e3297a5ba11a0294024
80 Nfac8090dd0b44c4abfc5c63696c4071e schema:name nlm_unique_id
81 schema:value 8702459
82 rdf:type schema:PropertyValue
83 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
84 schema:name Medical and Health Sciences
85 rdf:type schema:DefinedTerm
86 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
87 schema:name Cardiorespiratory Medicine and Haematology
88 rdf:type schema:DefinedTerm
89 sg:journal.1096890 schema:issn 0268-3369
90 1476-5365
91 schema:name Bone Marrow Transplantation
92 rdf:type schema:Periodical
93 sg:person.01022655101.07 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
94 schema:familyName Mailankody
95 schema:givenName Sham
96 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022655101.07
97 rdf:type schema:Person
98 sg:person.01025765740.48 schema:affiliation https://www.grid.ac/institutes/grid.414467.4
99 schema:familyName Kwok
100 schema:givenName Mary
101 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025765740.48
102 rdf:type schema:Person
103 sg:person.01027216756.04 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
104 schema:familyName Korde
105 schema:givenName Neha
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027216756.04
107 rdf:type schema:Person
108 sg:person.01073457472.48 schema:affiliation https://www.grid.ac/institutes/grid.410305.3
109 schema:familyName Panch
110 schema:givenName Sandhya
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073457472.48
112 rdf:type schema:Person
113 sg:person.01255463326.16 schema:affiliation https://www.grid.ac/institutes/grid.468189.a
114 schema:familyName Bhutani
115 schema:givenName Manisha
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255463326.16
117 rdf:type schema:Person
118 sg:person.01263341253.41 schema:affiliation https://www.grid.ac/institutes/grid.94365.3d
119 schema:familyName Stetler-Stevenson
120 schema:givenName Maryalice
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263341253.41
122 rdf:type schema:Person
123 sg:person.01312177474.73 schema:affiliation https://www.grid.ac/institutes/grid.410305.3
124 schema:familyName Leitman
125 schema:givenName Susan F.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312177474.73
127 rdf:type schema:Person
128 sg:person.01320171063.03 schema:affiliation https://www.grid.ac/institutes/grid.417082.8
129 schema:familyName Tageja
130 schema:givenName Nishant
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320171063.03
132 rdf:type schema:Person
133 sg:person.01331512034.78 schema:affiliation https://www.grid.ac/institutes/grid.94365.3d
134 schema:familyName Kazandjian
135 schema:givenName Dickran
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331512034.78
137 rdf:type schema:Person
138 sg:person.01347475463.08 schema:affiliation https://www.grid.ac/institutes/grid.410427.4
139 schema:familyName Sportes
140 schema:givenName Claude
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347475463.08
142 rdf:type schema:Person
143 sg:person.0640361324.84 schema:affiliation N20448333467e4335bcee6e358258f0db
144 schema:familyName Manasanch
145 schema:givenName Elisabet
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640361324.84
147 rdf:type schema:Person
148 sg:person.0640367641.74 schema:affiliation https://www.grid.ac/institutes/grid.94365.3d
149 schema:familyName Yuan
150 schema:givenName Constance
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640367641.74
152 rdf:type schema:Person
153 sg:person.0651746766.54 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
154 schema:familyName Landgren
155 schema:givenName Ola
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651746766.54
157 rdf:type schema:Person
158 sg:pub.10.1038/bmt.2016.24 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039064722
159 https://doi.org/10.1038/bmt.2016.24
160 rdf:type schema:CreativeWork
161 sg:pub.10.1038/sj.leu.2404801 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011029060
162 https://doi.org/10.1038/sj.leu.2404801
163 rdf:type schema:CreativeWork
164 https://app.dimensions.ai/details/publication/pub.1083110094 schema:CreativeWork
165 https://app.dimensions.ai/details/publication/pub.1083111450 schema:CreativeWork
166 https://doi.org/10.1001/jamaoncol.2015.2010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030075938
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/j.leukres.2013.12.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038752219
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/s1470-2045(16)30206-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042996950
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1182/blood-2008-03-143677 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038113449
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1182/blood-2016-03-705319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015788731
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1200/jco.2001.19.17.3771 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074873336
177 rdf:type schema:CreativeWork
178 https://doi.org/10.3324/haematol.10535 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039410376
179 rdf:type schema:CreativeWork
180 https://www.grid.ac/institutes/grid.410305.3 schema:alternateName National Institutes of Health Clinical Center
181 schema:name Cell Processing Section, Clinical Center, National Institutes of Health, Bethesda, MD, USA
182 rdf:type schema:Organization
183 https://www.grid.ac/institutes/grid.410427.4 schema:alternateName Augusta University
184 schema:name Bone Marrow and Stem Cell Transplantation Program, Augusta University, Augusta, GA, USA
185 rdf:type schema:Organization
186 https://www.grid.ac/institutes/grid.414467.4 schema:alternateName Walter Reed National Military Medical Center
187 schema:name Hematology/Oncology Department, John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, USA
188 rdf:type schema:Organization
189 https://www.grid.ac/institutes/grid.417082.8 schema:alternateName Wheeling Hospital
190 schema:name Division of Hematology/Oncology, Schiffler Cancer Center, Wheeling, WV, USA
191 rdf:type schema:Organization
192 https://www.grid.ac/institutes/grid.468189.a schema:alternateName Levine Cancer Institute
193 schema:name Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA
194 rdf:type schema:Organization
195 https://www.grid.ac/institutes/grid.51462.34 schema:alternateName Memorial Sloan Kettering Cancer Center
196 schema:name Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
197 rdf:type schema:Organization
198 https://www.grid.ac/institutes/grid.94365.3d schema:alternateName National Institutes of Health
199 schema:name Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
200 Myeloma Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
201 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...